These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 9882619)
1. Biochemical characterization of a variant human medium-chain acyl-CoA dehydrogenase with a disease-associated mutation localized in the active site. Küchler B; Abdel-Ghany AG; Bross P; Nandy A; Rasched I; Ghisla S Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):225-30. PubMed ID: 9882619 [TBL] [Abstract][Full Text] [Related]
2. Biochemical characterization of purified, human recombinant Lys304-->Glu medium-chain acyl-CoA dehydrogenase containing the common disease-causing mutation and comparison with the normal enzyme. Kieweg V; Kräutle FG; Nandy A; Engst S; Vock P; Abdel-Ghany AG; Bross P; Gregersen N; Rasched I; Strauss A; Ghisla S Eur J Biochem; 1997 Jun; 246(2):548-56. PubMed ID: 9208949 [TBL] [Abstract][Full Text] [Related]
3. Catalytic defect of medium-chain acyl-coenzyme A dehydrogenase deficiency. Lack of both cofactor responsiveness and biochemical heterogeneity in eight patients. Amendt BA; Rhead WJ J Clin Invest; 1985 Sep; 76(3):963-9. PubMed ID: 3840178 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of activation of acyl-CoA substrates by medium chain acyl-CoA dehydrogenase: interaction of the thioester carbonyl with the flavin adenine dinucleotide ribityl side chain. Engst S; Vock P; Wang M; Kim JJ; Ghisla S Biochemistry; 1999 Jan; 38(1):257-67. PubMed ID: 9890906 [TBL] [Abstract][Full Text] [Related]
5. Substrate activation by acyl-CoA dehydrogenases: transition-state stabilization and pKs of involved functional groups. Vock P; Engst S; Eder M; Ghisla S Biochemistry; 1998 Feb; 37(7):1848-60. PubMed ID: 9485310 [TBL] [Abstract][Full Text] [Related]
6. Medium-long-chain chimeric human Acyl-CoA dehydrogenase: medium-chain enzyme with the active center base arrangement of long-chain Acyl-CoA dehydrogenase. Nandy A; Kieweg V; Kräutle FG; Vock P; Küchler B; Bross P; Kim JJ; Rasched I; Ghisla S Biochemistry; 1996 Sep; 35(38):12402-11. PubMed ID: 8823175 [TBL] [Abstract][Full Text] [Related]
7. Characterization of wild-type and an active site mutant of human medium chain acyl-CoA dehydrogenase after expression in Escherichia coli. Bross P; Engst S; Strauss AW; Kelly DP; Rasched I; Ghisla S J Biol Chem; 1990 May; 265(13):7116-9. PubMed ID: 1970566 [TBL] [Abstract][Full Text] [Related]
9. Crystal structures of the wild type and the Glu376Gly/Thr255Glu mutant of human medium-chain acyl-CoA dehydrogenase: influence of the location of the catalytic base on substrate specificity. Lee HJ; Wang M; Paschke R; Nandy A; Ghisla S; Kim JJ Biochemistry; 1996 Sep; 35(38):12412-20. PubMed ID: 8823176 [TBL] [Abstract][Full Text] [Related]
10. Characterization of human and pig kidney long-chain-acyl-CoA dehydrogenases and their role in beta-oxidation. Eder M; Kräutle F; Dong Y; Vock P; Kieweg V; Kim JJ; Strauss AW; Ghisla S Eur J Biochem; 1997 May; 245(3):600-7. PubMed ID: 9182995 [TBL] [Abstract][Full Text] [Related]
11. The Y42H mutation in medium-chain acyl-CoA dehydrogenase, which is prevalent in babies identified by MS/MS-based newborn screening, is temperature sensitive. O'Reilly L; Bross P; Corydon TJ; Olpin SE; Hansen J; Kenney JM; McCandless SE; Frazier DM; Winter V; Gregersen N; Engel PC; Andresen BS Eur J Biochem; 2004 Oct; 271(20):4053-63. PubMed ID: 15479234 [TBL] [Abstract][Full Text] [Related]
12. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729 [TBL] [Abstract][Full Text] [Related]
13. Oxidase activity of the acyl-CoA dehydrogenases. DuPlessis ER; Pellett J; Stankovich MT; Thorpe C Biochemistry; 1998 Jul; 37(29):10469-77. PubMed ID: 9671517 [TBL] [Abstract][Full Text] [Related]
14. Biochemical characterisation of mutations of human medium-chain acyl-CoA dehydrogenase. Udvari S; Bross P; Andresen BS; Gregersen N; Engel PC Adv Exp Med Biol; 1999; 466():387-93. PubMed ID: 10709667 [No Abstract] [Full Text] [Related]
15. Structure and mechanism of action of the acyl-CoA dehydrogenases. Thorpe C; Kim JJ FASEB J; 1995 Jun; 9(9):718-25. PubMed ID: 7601336 [TBL] [Abstract][Full Text] [Related]
18. Effects of two mutations detected in medium chain acyl-CoA dehydrogenase (MCAD)-deficient patients on folding, oligomer assembly, and stability of MCAD enzyme. Bross P; Jespersen C; Jensen TG; Andresen BS; Kristensen MJ; Winter V; Nandy A; Kräutle F; Ghisla S; Bolundi L J Biol Chem; 1995 Apr; 270(17):10284-90. PubMed ID: 7730333 [TBL] [Abstract][Full Text] [Related]
19. Mutations in the medium chain acyl-CoA dehydrogenase (MCAD) gene. Tanaka K; Yokota I; Coates PM; Strauss AW; Kelly DP; Zhang Z; Gregersen N; Andresen BS; Matsubara Y; Curtis D Hum Mutat; 1992; 1(4):271-9. PubMed ID: 1363805 [TBL] [Abstract][Full Text] [Related]
20. The roles of threonine-136 and glutamate-137 of human medium chain acyl-CoA dehydrogenase in FAD binding and peptide folding using site-directed mutagenesis: creation of an FAD-dependent mutant, T136D. Saijo T; Kim JJ; Kuroda Y; Tanaka K Arch Biochem Biophys; 1998 Oct; 358(1):49-57. PubMed ID: 9750163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]